Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment

Sphingosine 1-phosphate (S1P) is a bioactive lipid involved in cancer progression through its binding to S1P receptors (S1PRs). However, the association between multiple myeloma (MM) and S1P is unclear. The current study aimed to investigate the potential anti-cancer effects of fingolimod and sphing...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yuko, Okabe, Seiichi, Ohyashiki, Kazuma, Gotoh, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850960/
https://www.ncbi.nlm.nih.gov/pubmed/35251342
http://dx.doi.org/10.3892/ol.2022.13231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850960/
https://www.ncbi.nlm.nih.gov/pubmed/35251342
http://dx.doi.org/10.3892/ol.2022.13231

Ejemplares similares